当代医学
噹代醫學
당대의학
CHINA CONTEMPORARY MEDICINE
2013年
26期
7-8
,共2页
刘孝华%张银高%阙新祥%梁骏%吴建华%谭大清%杨名
劉孝華%張銀高%闕新祥%樑駿%吳建華%譚大清%楊名
류효화%장은고%궐신상%량준%오건화%담대청%양명
根治性膀胱全切除术%蛇毒血凝酶%止血效果
根治性膀胱全切除術%蛇毒血凝酶%止血效果
근치성방광전절제술%사독혈응매%지혈효과
Radical cystectomy surgery%Hemocoagulase%Hemostatic effect
目的观察蛇毒血凝酶在行根治性膀胱全切除术术中和术后的止血效果。方法适合根治性膀胱全切术的膀胱癌患者30例,随机分成蛇毒血凝酶组和对照组,每组患者各15例。蛇毒血凝酶组术前15 min、术中分别静脉滴注蛇毒血凝酶1 U,用浸泡蛇毒血凝酶生理盐水溶液的纱布压迫盆腔创面止血,术后静脉滴注蛇毒血凝酶1 U/d,连续3 d;对照组用0.9%氯化钠注射液。分别记录术中出血量、术后3 d的腹腔及盆腔总引流量,同时观察蛇毒血凝酶对凝血指标的影响。结果蛇毒血凝酶组与对照组术中出血量分别为(358±105)g与(672±182)g,术后总引流量分别为(257±138)g和(356±166)g,以上指标蛇毒血凝酶组均少于对照组(P<0.05)。两组术前和术后凝血指标无明显差异(P>0.05)。结论蛇毒血凝酶在膀胱癌适合根治性膀胱全切术中具有显著的止血效果,安全性能良好,能明显缩短手术时间.减少术中、术后出血和围手术期的输血。
目的觀察蛇毒血凝酶在行根治性膀胱全切除術術中和術後的止血效果。方法適閤根治性膀胱全切術的膀胱癌患者30例,隨機分成蛇毒血凝酶組和對照組,每組患者各15例。蛇毒血凝酶組術前15 min、術中分彆靜脈滴註蛇毒血凝酶1 U,用浸泡蛇毒血凝酶生理鹽水溶液的紗佈壓迫盆腔創麵止血,術後靜脈滴註蛇毒血凝酶1 U/d,連續3 d;對照組用0.9%氯化鈉註射液。分彆記錄術中齣血量、術後3 d的腹腔及盆腔總引流量,同時觀察蛇毒血凝酶對凝血指標的影響。結果蛇毒血凝酶組與對照組術中齣血量分彆為(358±105)g與(672±182)g,術後總引流量分彆為(257±138)g和(356±166)g,以上指標蛇毒血凝酶組均少于對照組(P<0.05)。兩組術前和術後凝血指標無明顯差異(P>0.05)。結論蛇毒血凝酶在膀胱癌適閤根治性膀胱全切術中具有顯著的止血效果,安全性能良好,能明顯縮短手術時間.減少術中、術後齣血和圍手術期的輸血。
목적관찰사독혈응매재행근치성방광전절제술술중화술후적지혈효과。방법괄합근치성방광전절술적방광암환자30례,수궤분성사독혈응매조화대조조,매조환자각15례。사독혈응매조술전15 min、술중분별정맥적주사독혈응매1 U,용침포사독혈응매생리염수용액적사포압박분강창면지혈,술후정맥적주사독혈응매1 U/d,련속3 d;대조조용0.9%록화납주사액。분별기록술중출혈량、술후3 d적복강급분강총인류량,동시관찰사독혈응매대응혈지표적영향。결과사독혈응매조여대조조술중출혈량분별위(358±105)g여(672±182)g,술후총인류량분별위(257±138)g화(356±166)g,이상지표사독혈응매조균소우대조조(P<0.05)。량조술전화술후응혈지표무명현차이(P>0.05)。결론사독혈응매재방광암괄합근치성방광전절술중구유현저적지혈효과,안전성능량호,능명현축단수술시간.감소술중、술후출혈화위수술기적수혈。
Objective To observe the hemostatic effect of Hemocoagulase in intraoperative and postoperative of the radical cystectomy .Methods 30 cases with bladder cancer who were suitable for radical total cystectomy were randomly divided into the Hemocoagulase group and the control group, 15 cases in each group. 15 min before the operation and intraoperative, the Hemocoagulase group was respectively injected hemocoagulase 1 U. Etamine soaked with hemocoagulase physiological saline solution was used to oppress the pelvic wound for hemostasis. Hemocoagulase was injected for 3 days after operation, 1 U / d. At the same time, 0.9% sodium chloride was used in control group.Blood loss, abdominal and pelvic total lead flow for 3 days after operation were recorded, while observing the coagulation indicators. Results:Blood loss of the Hemocoagulase group and the control group respectively was (358 ± 105) g, (672 ± 182) g, total postoperative drainage volume was (257 ± 138) g . (356 ± 166) g. The above datas of the hemocoagulase group less than that of the control group (P<0.05). Coagulation indicators have no signiifcant difference (P>0.05) before and after operation. Conclusion Hemocoagulase has signiifcant hemostatic effect and sate in cases with bladder cancer who were suitable for radical total cystectomy, it can signiifcantly shorten the operation time, reduce intraoperative, postoperative bleeding and perioperative blood transfusion.